S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mohamad A. Hussein, MD
The Cleveland Clinic
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
141 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- University of California Davis Cancer Center
Davis, California, United States
- Sutter Roseville Medical Center
Roseville, California, United States
- Sutter Cancer Center
Sacramento, California, United States
- Ccop - Atlanta Regional
Atlanta, Georgia, United States
- Northside Hospital Cancer Center
Atlanta, Georgia, United States
- Piedmont Hospital
Atlanta, Georgia, United States
- Saint Joseph'S Hospital of Atlanta
Atlanta, Georgia, United States
- Wellstar Cobb Hospital
Austell, Georgia, United States
- Charles B. Eberhart Cancer Center at Dekalb Medical Center
Decatur, Georgia, United States
- Gwinnett Medical Center
Lawrenceville, Georgia, United States
- Kennestone Cancer Center at Wellstar Kennestone Hospital
Marietta, Georgia, United States
- Southern Regional Medical Center
Riverdale, Georgia, United States
- Cancer Research Center of Hawaii
Honolula, Hawaii, United States
- Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
- Oncare Hawaii, Incorporated - Kuakini
Honolulu, Hawaii, United States
- Oncare Hawaii, Incorporated - Lusitana
Honolulu, Hawaii, United States
- Queen'S Cancer Institute at Queen'S Medical Center
Honolulu, Hawaii, United States
- St. Francis Medical Center
Honolulu, Hawaii, United States
- Straub Clinic and Hospital, Incorporated
Honolulu, Hawaii, United States
- Kapiolani Medical Center at Pali Momi
‘Aiea, Hawaii, United States
- St. Luke'S Mountain States Tumor Institute - Boise
Boise, Idaho, United States
- Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois, United States
- St. Francis Hospital and Health Centers
Beech Grove, Indiana, United States
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas, United States
- Salina Regional Health Center
Salina, Kansas, United States
- St. Francis Comprehensive Cancer Center
Topeka, Kansas, United States
- Stormont-Vail Cancer Center
Topeka, Kansas, United States
- Wesley Medical Center
Wichita, Kansas, United States
- Louisiana State University Health Sciences Center - Monroe
Monroe, Louisiana, United States
- Feist-Weiller Cancer Center at Louisiana State University Health Sciences
Shreveport, Louisiana, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Battle Creek Health System Cancer Care Center
Battle Creek, Michigan, United States
- Bay Regional Medical Center
Bay City, Michigan, United States
- Mecosta County General Hospital
Big Rapids, Michigan, United States
- Ccop - Grand Rapids
Grand Rapids, Michigan, United States
- Lacks Cancer Center at Saint Mary'S Mercy Medical Center
Grand Rapids, Michigan, United States
- Metropolitan Hospital
Grand Rapids, Michigan, United States
- Spectrum Health Cancer Care - Butterworth Campus
Grand Rapids, Michigan, United States
- Holland Community Hospital
Holland, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2002
- Primary completion
- 31 Oct 2008
- Completion
- 31 Oct 2015
- Last update posted
- 8 Dec 2016
- Registered enrollment
- 147
- Registry id
- NCT00040937
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.